We are live on ! Find out more
Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $110B
1-Year Est. Return 4.8%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Fund
S&P 500
This Quarter Est. Return
-25.13%
1 Year Est. Return
+4.8%
3 Year Est. Return
+123.53%
5 Year Est. Return
+125.55%
10 Year Est. Return
+1,754.37%
AUM
$97.5B
AUM Growth
-$45.1B
Cap. Flow
-$1.57B
Cap. Flow %
-1.61%
Top 10 Hldgs %
35.7%
Holding
526
New
28
Increased
112
Reduced
187
Closed
33

Top Buys

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$691M
2
MELI icon
Mercado Libre
MELI
+$341M
3
SPOT icon
Spotify
SPOT
+$335M
4
WIX icon
WIX.com
WIX
+$315M
5
RBLX icon
Roblox
RBLX
+$233M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$334M
2
CBRE icon
CBRE Group
CBRE
+$310M
3
AMZN icon
Amazon
AMZN
+$302M
4
NVDA icon
NVIDIA
NVDA
+$296M
5
TTD icon
Trade Desk
TTD
+$255M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 27.49%
2 Healthcare 25.5%
3 Technology 17.13%
4 Communication Services 10.66%
5 Financials 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACMR icon
401
ACM Research
ACMR
$5.79B
$11K ﹤0.01%
660
BOC icon
402
Boston Omaha
BOC
$436M
$11K ﹤0.01%
529
EGHT icon
403
8x8 Inc
EGHT
$332M
$11K ﹤0.01%
2,045
JKHY icon
404
Jack Henry & Associates
JKHY
$11.1B
$11K ﹤0.01%
62
-9
-13% -$1.69K
LECO icon
405
Lincoln Electric
LECO
$15.4B
$11K ﹤0.01%
+91
New +$12K
THO icon
406
Thor Industries
THO
$4.14B
$11K ﹤0.01%
151
+18
+14% +$1.4K
AXNX
407
DELISTED
Axonics, Inc. Common Stock
AXNX
$11K ﹤0.01%
198
CHRS icon
408
Coherus Oncology
CHRS
$196M
$10K ﹤0.01%
1,431
EXPD icon
409
Expeditors International
EXPD
$23.2B
$10K ﹤0.01%
107
-19
-15% -$1.95K
FOXA icon
410
Fox Class A
FOXA
$26.9B
$10K ﹤0.01%
310
-49
-14% -$1.72K
PTCT icon
411
PTC Therapeutics
PTCT
$6.12B
$10K ﹤0.01%
246
RHI icon
412
Robert Half
RHI
$4.37B
$10K ﹤0.01%
131
SGMO
413
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$10K ﹤0.01%
+2,510
New +$10.9K
TXRH icon
414
Texas Roadhouse
TXRH
$13.7B
$10K ﹤0.01%
131
SMAR
415
DELISTED
Smartsheet Inc.
SMAR
$10K ﹤0.01%
311
MNTV
416
DELISTED
Momentive Global Inc. Common Stock
MNTV
$10K ﹤0.01%
1,095
AMD icon
417
Advanced Micro Devices
AMD
$789B
$9K ﹤0.01%
118
BRC icon
418
Brady Corp
BRC
$4.57B
$9K ﹤0.01%
200
VISN
419
Vistance Networks Inc
VISN
$2.52B
$9K ﹤0.01%
1,442
DOMO icon
420
Domo
DOMO
$184M
$9K ﹤0.01%
321
DRI icon
421
Darden Restaurants
DRI
$24.4B
$9K ﹤0.01%
82
FATE icon
422
Fate Therapeutics
FATE
$326M
$9K ﹤0.01%
+372
New +$10.3K
NKE icon
423
Nike
NKE
$61.9B
$9K ﹤0.01%
90
SYK icon
424
Stryker
SYK
$130B
$9K ﹤0.01%
47
-7
-13% -$1.64K
TU icon
425
Telus
TU
$15.3B
$9K ﹤0.01%
397

Similar funds

Baillie Gifford & Co's Q2 2022 Portfolio in Review

As of Q2 2022, Baillie Gifford & Co held 526 positions worth $97.5B, down 32% from $143B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Baillie Gifford & Co's Q2 2022 filing shows 28 new, 112 increased, 187 reduced and 33 closed positions. Its largest new stake was Hershey: 94,977 shares worth $20.4M. The largest sale was Tesla, an estimated $334M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Technology.

  • Baillie Gifford & Co's largest Q2 2022 buy was Hershey: 94,977 shares worth $20.4M.
  • Baillie Gifford & Co added most to Royalty Pharma in Q2 2022, an estimated $691M increase.
  • Baillie Gifford & Co's biggest Q2 2022 reduction was Tesla, cutting an estimated $334M.
  • Baillie Gifford & Co fully exited iShares Silver Trust in Q2 2022, selling an estimated $21.2M.
  • Baillie Gifford & Co's ten largest holdings make up 36% of its $97.5B portfolio in Q2 2022.
  • Baillie Gifford & Co opened 28 new positions and closed 33 in Q2 2022.
  • Baillie Gifford & Co's portfolio value fell 32% quarter-over-quarter to $97.5B.

Based on Baillie Gifford & Co's 13F filing for Q2 2022, filed 8 Aug 2022.